- $1.52bn
- $1.20bn
- $411.33m
Brief: Innoviva Specialty Therapeutics Signs Exclusive Distribution And Licensing Agreement To Acquire U.S. Marketing Rights For Zevtera®
Brief: Basilea Announces Agreement With Innoviva Specialty Therapeutics For Commercialization Of Zevtera In The United States
Innoviva Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Innoviva Q3 Royalty Revenue USD 57.056 Million
Innoviva Inc reports results for the quarter ended in June - Earnings Summary
Brief: Innoviva Q2 Net Income USD -34.685 Million
Innoviva Inc expected to post earnings of 24 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop
Brief: Innoviva Q1 Net Income USD 36.532 Million
Innoviva Inc expected to post earnings of 17 cents a share - Earnings Preview
Brief: Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement With Innoviva
Innoviva Inc reports results for the quarter ended in December - Earnings Summary
Brief: Innoviva Q4 EPS USD 0.76
Innoviva Inc expected to post earnings of 23 cents a share - Earnings Preview
Brief: Innoviva Q3 EPS USD 0.98
Brief: Innoviva Appoints Stephen Basso As Chief Financial Officer
Brief: Innoviva Inc On Aug 2, Received Non-compliance Notice From Nasdaq On Audit Committee Composition Requirements
Brief: Innoviva Q2 EPS USD 0.02
Innoviva Inc expected to post earnings of 26 cents a share - Earnings Preview